Waldemar Link GmbH & Co. KG is a private company headquartered in Hamburg, Germany, with subsidiaries in the United States and Sweden, that supplies orthopedic products. The firm was founded in 1948. Helmut D. Link, Norbert Ostwald and Peter Heinz Willenborg are the current co-CEOs of the company.

Boston Scientific Scimed, Inc. develops, manufactures, and markets medical devices used principally to treat cardiovascular disease.

DOT GmbH is a German private company located in Rostock. The firm develops medical coating technology for implants and instruments as well as their clean room packaging. It was founded in 1992. Hans W. Eifeler, Hans-Georg Neumann and Axel Baumann are the current co-CEOs of the company.\nThe company says this about itself: DOT is one of the leading companies in the field of medical coating technology for implants and instruments and also their cleanroom packaging. The development and manufacture of implants and \"regenerative medicine\" products for dental and orthopaedic applications are further fields of activity where DOT employees make their committed contribution to a better quality of life. DOT GmbH was established in February 1992 in Rostock as a coatings company by two physicists and two engineers. The founders had long standing industrial and scientific competence in the field of coating and materials technology. This expertise was the cornerstone for the successful development of the company.

Ionbond LLC manufactures coating systems. The company is headquartered in Madison Heights, MI.

Shenzhen Shankang Pharmaceutical Technology Co., Ltd., established on 2017-10-24, Business scope includes general business items:Research in Medical Technology,development and transfer;Medical Technology Services;Medical Technology Consulting,Information Consulting;Medical Device Research,development and transfer;Invest in business,Medical project investment;Domestic Trade;Import and export of goods or technology;Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:drug research,development and sales;Internet hospital services relying on physical hospitals;The second type of value-added telecommunications services;Sales of Class II Medical Devices;Internet culture management.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Doxa AB engages in the development, manufacture, and commercialization of bioceramic dental products. It carries the brand Ceramir Crown & Bridge, offers dental cement for permanent cementation of conventional prosthetics, including whole ceramic structures with aluminum oxide or zirconia bodies. The company was founded by Leif Hermansson and Irmeli Hermansson in 1987 and is headquartered in Uppsala, Sweden.

Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ.

Picosun is the leading manufacturer of Atomic Layer Deposition (ALD) reactors for micro- and nanotechnology applications. Picosun provides the customers with versatile, reliable, and user-friendly ALD process tools, which offer world leading process quality and unique scalability from basic research to fully automated high throughput industrial production. Picosun is based in Espoo, Finland, its production facilities are located in Masala (Kirkkonummi), Finland, its US headquarters in Detroit, Michigan, and its Asian headquarters in Singapore. PICOSUN™ ALD process tools have been installed in various prominent industries and high-level reasearch organizations across Europe, USA, Asia and Australia. Picosun has world-wide sales and support network with distributors and representatives in over 30 countries.

Thommen Medical develops, produces and sells dental implants under the brand name SPI (Swiss Precision Implant) as well as biomaterial solutions for bone and tissue regeneration. Thommen Medical Implants are designed to be precise and easy to use, thanks to collaboration with leading scientific and dental clinicians.

Part of Einhorn Verwaltungsgesellschaft mbH, Heraeus Medical GmbH is a company headquartered in Wehrheim, Germany, that produces bone cement for joint fixation. Rolft Wetzel and Jan Rinnert are the current co-CEOs of the firm.

Axcelon Biopolymers Corp. provides medical devices for human health applications. It provides devices to those companies which uses nanotechnology to biodegradable polymer design and applications. Its technology includes stent coating, ophthalmology, drug delivery and regenerative medicine. The company is headquartered in Toronto, Canada

Part of BIOTRONIK SE & Co. KG, Biotronik AG is a Swiss company located in Bulach that manufactures devices for vascular intervention and electrotherapy of heart.\nThe company says this about itself: BIOTRONIK is a leading medical device company that has been developing trusted and innovative cardiovascular and endovascular solutions for more than 50 years. Driven by a purpose to perfectly match technology with the human body, BIOTRONIK innovations deliver care that saves and improves the lives of millions diagnosed with heart and blood vessel diseases every year. BIOTRONIK is headquartered in Berlin, Germany, and represented in over 100 countries.

Manufactures pharmaceutical products

Smith & Nephew PLC designs, manufactures and markets orthopedic devices, sports medicine and ENT technologies, and wound-care solutions. Slightly more than 40% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is a sports medicine and ENT. The remaining 27% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Gebr. Brasseler GmbH & Co. KG is a private company headquartered in Lemgo, Germany, that manufactures medical apparatus and instruments. It was founded in 2019. Stephan K��hler, Klaus R��besamen and Reinhard H��lscher are the current co-CEOs of the firm.\nThe company says this about itself: Gebr. Brasseler GmbH & Co. KG engages in the design and development, manufacture and distribution of medical devices and products for dental laboratories and industry.

Warantec Co., Ltd. engages in the provision of dental implant services. Its products include Sinus Kit and Oneplant Solution Kit. The company was founded on December 28, 2001 and is headquartered in Seongnam-si, South Korea.

Osstem develops and produces dental implants for dental treatment featuring dental equipment. They develop 3D printing and milling materials which are core materials of digital dentistry and repair materials. They provide total solutions for dental treatment featuring dental equipment, materials, and pharmaceutical products. Their development and sales of medical equipment including unit chairs, CTS, and panorama imaging devices.

CarboFix Orthopedics Ltd. engages in the development, manufacture, and marketing of solutions for trauma and spine. Its products include CarboClear cervical plate, CarboClear pedicle screw, proximal humerus plate, CarboClear lumbar cage, and distal fibula plate. The company was founded Mordechay Beyar in 2011 and is headquartered in Herzliya, Israel.

The University of Texas Health Science Center at San Antonio serves San Antonio and the 50,000 square-mile area of South Texas. It extends to campuses in the metropolitan border communities of Laredo and the Rio Grande Valley. More than 3,000 students a year train in an environment that involves more than 100 affiliated hospitals, clinics and health care facilities in South Texas. The UT Health Science Center and its Cancer Therapy & Research Center hold diversity as a core value. In this context, they are mindful of all aspects of human differences, such as socioeconomic status, race, ethnicity, language, nationality, sex, gender identity, sexual orientation, religion, geography, disability and age. At the UT Health Science Center and CTRC, inclusion is a core element for successfully achieving diversity, as they strive to create a climate that fosters belonging, respect and value for all. As an equal employment opportunity and affirmative action employer, the UT Health Science Center and CTRC exercise these core values of diversity and inclusion by promoting and ensuring equal employment opportunity for all individuals without regard to race, color, religion, sex, national origin, age, sexual orientation, disability, or veteran status.